VVD-300

N/A

Report date: 2025/01/26 16:27:48
NME

Base Information

Drug NameVVD-300
Drug Alias NameJAK1 inhibitor (Vividion)VVD-300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVividion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVividion Therapeutics Inc
Inactive CompaniesN/A
Active Indications +[1]  N/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A